Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hydropothecary in deal with Segra ahead of cannabis legalization

Stockhouse Editorial
0 Comments| March 16, 2018

{{labelSign}}  Favorites
{{errorMessage}}

The Hydropothecary Corp. (TSX V.THCX, HYYDF, Forum) on Friday announced its agreement with Segra International Corp. to incorporate plant tissue culture propogation in the cannabis plant production process.

Segra’s expertise and unique tissue culture technique will allow Hydropothecary to increase its yield of healthy, top-quality plants to serve the growing medical and recreational cannabis markets.

More information can be found here.

The Hydropothecary Corp. was in the news recently when it received two prestigious awards for Best New Cannabis Product at the inaugural Canadian Cannabis Awards gala.

FULL DISCLOSURE: The Hydropothecary Corp. is a paid client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company